Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Acumen Pharmaceuticals, Inc. (ABOS)
USD2.26
-0.27 (-10.68%)
US NASDAQ Healthcare Biotechnology
Address
427 Park Street 22902
Newton, VA, US
Newton, VA, US
CEO
Daniel J. O'Connell
Website
acumenpharm.com
IPO
2021-07-01
CIK 1576885 ISIN US00509G2093
Description
Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in Phase I clinical trials, where it is designed to specifically target soluble amyloid-beta oligomers. The firm was established in 1996 and maintains its principal headquarters in Charlottesville, Virginia.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.26
-0.27 (-10.68%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
466.7K
Beta
0.35
Float Shares
46.35M
Free Float %
76.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.50% | -2.36% | +0.40% | +3.77% | +27.18% | +17.54% | +136.19% | -55.71% | -87.66% | -87.66% | -87.66% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
2.26
Low
7.00
+209.8%
Consensus
7.00
+209.8%
Median
7.00
+209.8%
High
7.00
+209.8%
DCF (Unlevered)
0.38
-83.4%
DCF (Levered)
0.37
-83.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 6 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 1 |
7.00
+209.8%
|
Quality scores
Altman Z-Score
-4.76
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%-17.0% Q1'26: +31.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+0.9% ★ Q1'26: +4.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.25× Q1'26: -0.17× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 EPS Ana. |
Dec 2027 1 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 7.50M (-100.0%)
|
—
|
—
|
—
— – —
|
—
— – —
|
11.60M
11.60M – 11.60M
|
56.19M
56.19M – 56.19M
+384.5% YoY
|
| EBITDA |
-51.61M
est: 4.50M (-1,246.8%)
|
-98.08M
|
-123.83M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-51.79M
est: 4.50M (-1,250.9%)
|
-98.26M
|
-123.83M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-52.37M
est: -64.35M (+18.6%)
|
-102.33M
est: -97.50M (-5.0%)
|
-121.34M
est: -121.34M (+0.0%)
|
-95.26M
-118.10M – -81.15M
+21.5% YoY
|
-85.84M
-85.84M – -85.84M
+9.9% YoY
|
-53.08M
-79.40M – -26.76M
+38.2% YoY
|
-73.58M
-73.58M – -73.58M
-38.6% YoY
|
| SGA |
18.82M
est: 7.41M (+153.9%)
|
20.22M
|
18.95M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-1.08
est: -1.07 (-0.7%)
|
-1.71
est: -1.60 (-6.6%)
|
-2.00
est: -2.05 (+2.3%)
|
-1.61
-1.95 – -1.34
+21.2% YoY
|
-1.42
-1.42 – -1.42
+12.1% YoY
|
-0.88
-1.31 – -0.44
+38.2% YoY
|
-1.22
-1.22 – -1.22
-38.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-05 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-04 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-01 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-115.54M
OE per share TTM
-1.91
Owner's Yield
-74.23%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
36.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
13
Total invested
2.25M
Insider transactions (90d)
0
Beneficial owners (>5%)
18
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Peter Kolchinsky | 9.77M | 25.30% | — | 9.77M | — | 10.00 | HC, IN | United States | 2021-07-16 | ↗ |
| 2 | RA Capital Management, L.P. | 9.77M | 25.30% | — | 9.77M | — | 10.00 | IA, PN | Delaware | 2021-07-16 | ↗ |
| 3 | Rajeev Shah | 9.77M | 25.30% | — | 9.77M | — | 10.00 | HC, IN | United States | 2021-07-16 | ↗ |
| 4 | RA Capital Healthcare Fund, L.P. | 7.88M | 20.40% | — | 7.88M | — | 10.00 | PN | Delaware | 2021-07-16 | ↗ |
| 5 | Paul B. Manning | 4.01M | 9.90% | 3.35M | 658.0K | 3.35M | 658.0K | IN | Delaware | 2022-02-15 | ↗ |
| 6 | Molly G. Hardie | 3.45M | 8.50% | — | 3.45M | — | 3.45M | HC, IN | United States of America | 2022-02-16 | ↗ |
| 7 | Robert D. Hardie | 3.45M | 8.50% | — | 3.45M | — | 3.45M | HC, IN | United States of America | 2022-02-16 | ↗ |
| 8 | Frank M. Sands | 3.42M | 8.84% | — | 3.42M | — | 3.42M | IN | State of Delaware | 2021-07-13 | ↗ |
| 9 | The Paul B. Manning Revocable Trust dated May 10, 2000 | 3.04M | 7.50% | 3.04M | — | 3.04M | — | OO | Virginia | 2022-02-15 | ↗ |
| 10 | James B. Murray, Jr. | 2.58M | 6.40% | 2.58M | — | 2.58M | — | IN | — | 2022-02-14 | ↗ |
| 11 | David Kroin | 2.41M | 5.97% | — | 2.41M | — | — | HC, IN | Delaware | 2022-01-27 | ↗ |
| 12 | Deep Track Biotechnology Master Fund, Ltd. | 2.41M | 5.97% | — | 2.41M | — | — | CO | Delaware | 2022-01-27 | ↗ |
| 13 | Deep Track Capital, LP | 2.41M | 5.97% | — | 2.41M | — | — | IA, OO | Delaware | 2022-01-27 | ↗ |
| 14 | Sands Capital Global Venture Fund II, L.P. | 1.15M | 2.97% | — | 1.15M | — | 1.15M | PN | State of Delaware | 2021-07-13 | ↗ |
| 15 | Sands Capital Life Sciences Pulse Fund, LLC | 1.15M | 2.97% | — | 1.15M | — | 1.15M | OO | State of Delaware | 2021-07-13 | ↗ |
| 16 | Sands Capital Ventures Discovery Fund III, L.P. | 1.12M | 2.91% | — | 1.12M | — | 1.12M | PN | State of Delaware | 2021-07-13 | ↗ |
| 17 | (1) BlackRock, Inc. | 1.12M | 2.80% | 1.12M | — | 1.12M | — | HC | Delaware | 2022-10-07 | ↗ |
| 18 | BKB Growth Investments, LLC | 658.0K | 1.60% | 658.0K | — | 658.0K | — | OO | Delaware | 2022-02-15 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
13
-58 vs prev Q
New positions
1
Closed positions
58
Increased
5
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 14.93M +— (+0.0%) | 31.51M +6.0M (+23.4%) | 24.65% +0.000 pp | 0.32% +0.008 pp | USD11.16 -81.1% | 18 qtrs — |
| 2 | SANDS CAPITAL VENTURES, LLC | 3.42M +— (+0.0%) | 7.21M +1.4M (+23.4%) | 5.64% +0.000 pp | 1.39% +0.110 pp | USD14.86 -85.8% | 18 qtrs — |
| 3 | FRANKLIN RESOURCES INC | 2.31M +— (+0.0%) | 4.86M +922.0K (+23.4%) | 3.81% +0.000 pp | 0.00% +0.000 pp | USD4.02 -47.5% | 10 qtrs — |
| 4 | FMR LLC | 2.03M -1.8K (-0.1%) | 4.28M +807.9K (+23.3%) | 3.35% -0.003 pp | 0.00% +0.000 pp | USD4.00 -47.3% | 18 qtrs — |
| 5 | VANGUARD GROUP INC | 1.65M +2.3K (+0.1%) | 3.49M +665.4K (+23.6%) | 2.73% +0.004 pp | 0.00% +0.000 pp | USD5.35 -60.6% | 18 qtrs — |
| 6 | KNOLLWOOD INVESTMENT ADVISORY, LLC | 1.63M +— (+0.0%) | 3.44M +651.4K (+23.4%) | 2.69% +0.000 pp | 0.32% +0.072 pp | USD5.40 -60.9% | 13 qtrs — |
| 7 | ALYESKA INVESTMENT GROUP, L.P. | 939.6K +— (+0.0%) | 1.98M +375.8K (+23.4%) | 1.55% +0.000 pp | 0.01% +0.001 pp | USD4.08 -48.3% | 10 qtrs — |
| 8 | ADAR1 CAPITAL MANAGEMENT, LLC | 891.2K +— (+0.0%) | 1.88M +356.5K (+23.4%) | 1.47% +0.000 pp | 0.14% -0.005 pp | USD1.21 +74.4% | 5 qtrs — |
| 9 | LAURION CAPITAL MANAGEMENT LP | 867.0K +— (+0.0%) | 1.83M +346.8K (+23.4%) | 1.43% +0.000 pp | 0.07% +0.043 pp | USD8.02 -73.7% | 18 qtrs — |
| 10 | PATHSTONE HOLDINGS, LLC | 859.1K +— (+0.0%) | 1.81M +343.6K (+23.4%) | 1.42% +0.000 pp | 0.01% +0.001 pp | USD2.41 -12.4% | 9 qtrs — |
| 11 | HUDSON BAY CAPITAL MANAGEMENT LP | 725.0K -4.0 (0.0%) | 1.53M +290.0K (+23.4%) | 1.20% +0.000 pp | 0.01% +0.001 pp | USD3.64 -42.0% | 13 qtrs — |
| 12 | MILLENNIUM MANAGEMENT LLC | 584.1K -17.6K (-2.9%) | 1.23M +203.6K (+19.8%) | 0.96% -0.029 pp | 0.00% +0.000 pp | USD3.02 -30.1% | 17 qtrs — |
| 13 | RENAISSANCE TECHNOLOGIES LLC | 423.1K -161.2K (-27.6%) | 892.7K -106.4K (-10.6%) | 0.70% -0.266 pp | 0.00% +0.000 pp | USD1.99 +6.0% | 7 qtrs — |
| 14 | TWO SIGMA ADVISERS, LP | 421.8K -1.8K (-0.4%) | 890.0K +165.6K (+22.9%) | 0.70% -0.003 pp | 0.00% +0.000 pp | USD3.03 -30.4% | 10 qtrs — |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 410.2K +11.4K (+2.9%) | 865.7K +183.6K (+26.9%) | 0.68% +0.019 pp | 0.00% +0.000 pp | USD3.71 -43.1% | 18 qtrs — |
| 16 | SG AMERICAS SECURITIES, LLC | 401.0K -2.8K (-0.7%) | 846.0K +155.0K (+22.4%) | 0.66% -0.005 pp | 0.00% -0.001 pp | USD1.71 +23.4% | 8 qtrs — |
| 17 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 373.2K +158.8K (+74.0%) | 787.4K +420.8K (+114.7%) | 0.62% +0.262 pp | 0.00% +0.000 pp | USD2.09 +1.0% | 15 qtrs — |
| 18 | CITADEL ADVISORS LLC | 345.3K -148.8K (-30.1%) | 728.5K -116.4K (-13.8%) | 0.57% -0.246 pp | 0.00% +0.000 pp | USD1.71 +23.4% | 2 qtrs — |
| 19 | IKARIAN CAPITAL, LLC | 254.3K -11.5K (-4.3%) | 536.6K +82.1K (+18.1%) | 0.42% -0.019 pp | 0.04% -0.004 pp | USD6.84 -69.2% | 14 qtrs — |
| 20 | BANK OF AMERICA CORP /DE/ | 240.2K +26.4K (+12.4%) | 506.7K +141.2K (+38.6%) | 0.40% +0.044 pp | 0.00% +0.000 pp | USD2.65 -20.4% | 18 qtrs — |
| 21 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 170.2K -20.0K (-10.5%) | 359.1K +33.9K (+10.4%) | 0.28% -0.033 pp | 0.01% +0.001 pp | USD3.10 -31.9% | 16 qtrs — |
| 22 | BLACKROCK, INC. | 169.5K -5.2K (-3.0%) | 357.7K +58.9K (+19.7%) | 0.28% -0.009 pp | 0.00% +0.000 pp | USD2.47 -14.6% | 6 qtrs — |
| 23 | MORGAN STANLEY | 166.9K +17.5K (+11.7%) | 352.2K +96.7K (+37.8%) | 0.28% +0.029 pp | 0.00% +0.000 pp | USD2.65 -20.4% | 18 qtrs — |
| 24 | ACADIAN ASSET MANAGEMENT LLC | 152.8K +74.9K (+96.1%) | 320.0K +189.0K (+144.3%) | 0.25% +0.124 pp | 0.00% +0.000 pp | USD1.91 +10.5% | 2 qtrs — |
| 25 | TWO SIGMA INVESTMENTS, LP | 143.2K -56.2K (-28.2%) | 302.2K -38.9K (-11.4%) | 0.24% -0.093 pp | 0.00% 0.000 pp | USD3.39 -37.8% | 15 qtrs — |
| 26 | JANE STREET GROUP, LLC | 142.1K -65.1K (-31.4%) | 299.9K -54.5K (-15.4%) | 0.23% -0.108 pp | 0.00% +0.000 pp | USD1.38 +52.9% | 13 qtrs — |
| 27 | GOLDMAN SACHS GROUP INC | 117.9K -29.3K (-19.9%) | 248.7K -3.0K (-1.2%) | 0.19% -0.048 pp | 0.00% +0.000 pp | USD2.00 +5.5% | 18 qtrs — |
| 28 | STATE STREET CORP | 100.2K -6.5K (-6.1%) | 211.4K +29.0K (+15.9%) | 0.17% -0.011 pp | 0.00% +0.000 pp | USD3.18 -33.6% | 18 qtrs — |
| 29 | CATALYST FINANCIAL PARTNERS LLC | 89.7K +— (+0.0%) | 189.3K +35.9K (+23.4%) | 0.15% +0.000 pp | 0.02% +0.003 pp | USD4.81 -56.1% | 11 qtrs — |
| 30 | NORTHERN TRUST CORP | 75.2K +10.3K (+15.8%) | 158.7K +47.6K (+42.9%) | 0.12% +0.017 pp | 0.00% +0.000 pp | USD3.02 -30.1% | 18 qtrs — |
| 31 | PROSPERA FINANCIAL SERVICES INC | 50.0K +50.0K (+100.0%) | 105.5K +105.5K (+100.0%) | 0.08% +0.083 pp | 0.00% +0.002 pp | USD2.11 +0.0% | 1 qtrs NEW |
| 32 | XTX TOPCO LTD | 49.6K +49.6K (+100.0%) | 104.6K +104.6K (+100.0%) | 0.08% +0.082 pp | 0.00% +0.003 pp | USD2.11 +0.0% | 1 qtrs NEW |
| 33 | DIMENSIONAL FUND ADVISORS LP | 49.1K +5.5K (+12.7%) | 103.5K +29.1K (+39.1%) | 0.08% +0.009 pp | 0.00% +0.000 pp | USD2.97 -29.0% | 12 qtrs — |
| 34 | QUADRATURE CAPITAL LTD | 49.0K +49.0K (+100.0%) | 103.5K +103.5K (+100.0%) | 0.08% +0.081 pp | 0.00% +0.001 pp | USD2.11 +0.0% | 1 qtrs NEW |
| 35 | QUBE RESEARCH & TECHNOLOGIES LTD | 48.0K +15.1K (+45.9%) | 101.2K +45.0K (+80.1%) | 0.08% +0.025 pp | 0.00% +0.000 pp | USD2.17 -2.8% | 15 qtrs — |
| 36 | BOOTHBAY FUND MANAGEMENT, LLC | 39.6K -11.5K (-22.4%) | 83.5K -3.8K (-4.3%) | 0.07% -0.019 pp | 0.00% +0.000 pp | USD4.61 -54.2% | 15 qtrs — |
| 37 | POINT72 ASSET MANAGEMENT, L.P. | 36.4K +36.4K (+100.0%) | 76.7K +76.7K (+100.0%) | 0.06% +0.060 pp | 0.00% +0.000 pp | USD2.11 +0.0% | 1 qtrs NEW |
| 38 | INTREPID FINANCIAL PLANNING GROUP LLC | 30.2K +— (+0.0%) | 63.6K +12.1K (+23.4%) | 0.05% +0.000 pp | 0.02% +0.005 pp | USD4.39 -51.9% | 13 qtrs — |
| 39 | BARCLAYS PLC | 30.0K -32.0K (-51.6%) | 63.3K -90.5K (-58.8%) | 0.05% -0.053 pp | 0.00% +0.000 pp | USD2.37 -11.0% | 16 qtrs — |
| 40 | CATALYST FUNDS MANAGEMENT PTY LTD | 29.6K +— (+0.0%) | 62.5K +11.8K (+23.4%) | 0.05% +0.000 pp | 0.01% +0.007 pp | USD1.34 +57.5% | 3 qtrs — |
| 41 | OMERS ADMINISTRATION CORP | 22.5K +22.5K (+100.0%) | 47.4K +47.4K (+100.0%) | 0.04% +0.037 pp | 0.00% +0.000 pp | USD2.11 +0.0% | 1 qtrs NEW |
| 42 | UBS GROUP AG | 21.6K -9.3K (-30.1%) | 45.5K -7.2K (-13.7%) | 0.04% -0.015 pp | 0.00% +0.000 pp | USD1.91 +10.5% | 18 qtrs — |
| 43 | MARSHALL WACE, LLP | 20.9K +20.9K (+100.0%) | 44.1K +44.1K (+100.0%) | 0.03% +0.035 pp | 0.00% +0.000 pp | USD2.11 +0.0% | 3 qtrs — |
| 44 | INDEPENDENT ADVISOR ALLIANCE | 19.0K +19.0K (+100.0%) | 40.1K +40.1K (+100.0%) | 0.03% +0.031 pp | 0.00% +0.001 pp | USD2.11 +0.0% | 1 qtrs NEW |
| 45 | PFG INVESTMENTS, LLC | 19.0K +7.5K (+65.2%) | 40.1K +20.4K (+103.9%) | 0.03% +0.012 pp | 0.00% +0.001 pp | USD1.87 +12.8% | 2 qtrs — |
| 46 | PINNACLE WEALTH MANAGEMENT ADVISORY GROUP, LLC | 18.0K +— (+0.0%) | 38.0K +7.2K (+23.4%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD4.01 -47.4% | 11 qtrs — |
| 47 | PINNACLE ASSOCIATES LTD | 18.0K +— (+0.0%) | 38.0K +7.2K (+23.4%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD1.72 +22.7% | 11 qtrs — |
| 48 | CLUNE & ASSOCIATES, LTD. | 16.5K +— (+0.0%) | 34.8K +6.6K (+23.4%) | 0.03% +0.000 pp | 0.01% +0.001 pp | USD1.72 +22.7% | 5 qtrs — |
| 49 | VIRTU FINANCIAL LLC | 10.9K +10.9K (+100.0%) | 23.0K +23.0K (+100.0%) | 0.02% +0.018 pp | 0.00% +0.001 pp | USD2.11 +0.0% | 1 qtrs NEW |
| 50 | NINE MASTS CAPITAL LTD | 10.6K +10.6K (+100.0%) | 22.4K +22.4K (+100.0%) | 0.02% +0.018 pp | 0.00% +0.004 pp | USD2.11 +0.0% | 1 qtrs NEW |
| 51 | WELLS FARGO & COMPANY/MN | 7.1K +600.0 (+9.2%) | 15.0K +3.9K (+34.8%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD2.26 -6.6% | 18 qtrs — |
| 52 | ADVISOR GROUP HOLDINGS, INC. | 6.9K -400.0 (-5.5%) | 14.5K +4.1K (+39.2%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD2.61 -19.2% | 10 qtrs — |
| 53 | GROUP ONE TRADING, L.P. | 4.8K -3.0K (-39.1%) | 10.0K -3.3K (-24.8%) | 0.01% -0.005 pp | 0.00% +0.000 pp | USD1.61 +31.1% | 14 qtrs — |
| 54 | TOWER RESEARCH CAPITAL LLC (TRC) | 4.5K +4.5K (+100.0%) | 9.4K +9.4K (+100.0%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD2.11 +0.0% | 18 qtrs — |
| 55 | LARSON FINANCIAL GROUP LLC | 4.3K +348.0 (+8.7%) | 9.2K +2.3K (+34.1%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD1.74 +21.3% | 2 qtrs — |
| 56 | PNC FINANCIAL SERVICES GROUP, INC. | 3.1K +— (+0.0%) | 6.5K +1.2K (+23.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.11 +90.1% | 4 qtrs — |
| 57 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 3.0K +— (+0.0%) | 6.3K +1.2K (+23.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.71 +23.4% | 2 qtrs — |
| 58 | TFC FINANCIAL MANAGEMENT, INC. | 2.5K +— (+0.0%) | 5.3K +1.0K (+23.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.71 +23.4% | 2 qtrs — |
| 59 | ROYAL BANK OF CANADA | 2.3K +1.2K (+103.8%) | 5.0K +3.0K (+150.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD2.04 +3.4% | 18 qtrs — |
| 60 | JPMORGAN CHASE & CO | 2.4K -623.0 (-20.5%) | 4.2K -1.1K (-20.5%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD1.80 +17.2% | 18 qtrs — |
| 61 | NISA INVESTMENT ADVISORS, LLC | 1.2K +— (+0.0%) | 2.6K +491.0 (+23.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.16 +81.9% | 6 qtrs — |
| 62 | BNP PARIBAS ARBITRAGE, SNC | 1.2K +— (+0.0%) | 2.6K +490.0 (+23.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.72 +22.7% | 5 qtrs — |
| 63 | EVERSOURCE WEALTH ADVISORS, LLC | 407.00 +— (+0.0%) | 859.00 +163.0 (+23.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.10 +91.8% | 4 qtrs — |
| 64 | FLAGSHIP HARBOR ADVISORS, LLC | 350.00 +350.0 (+100.0%) | 739.00 +739.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD2.11 +0.0% | 1 qtrs NEW |
| 65 | SBI SECURITIES CO., LTD. | 323.00 -195.0 (-37.6%) | 682.00 -204.0 (-23.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.63 +29.4% | 5 qtrs — |
| 66 | FARTHER FINANCE ADVISORS, LLC | 200.00 +— (+0.0%) | 422.00 +80.0 (+23.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.16 +81.9% | 3 qtrs — |
| 67 | NBT BANK N A /NY | 2.00 +— (+0.0%) | 422.00 +80.0 (+23.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +111.0% | 3 qtrs — |
| 68 | CLEARSTEAD ADVISORS, LLC | 60.00 +60.0 (+100.0%) | 127.00 +127.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.10 +0.5% | 3 qtrs — |
| 69 | SRS CAPITAL ADVISORS, INC. | 26.00 +— (+0.0%) | 55.00 +11.0 (+25.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.69 +24.9% | 2 qtrs — |
| 70 | OPTIVER HOLDING B.V. | 5.00 -1.0 (-16.7%) | 11.00 +1.0 (+10.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.60 +31.9% | 2 qtrs — |
| 71 | SAVANT CAPITAL, LLC | — -11.0K (-100.0%) | — -18.9K (-100.0%) | 0.00% -0.018 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 72 | CWM, LLC | — -744.0 (-100.0%) | — -1.0K (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 73 | CITIGROUP INC | — -151.0 (-100.0%) | — -258.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 18 qtrs SOLD |
| 74 | BELL INVESTMENT ADVISORS, INC | — -362.0 (-100.0%) | — -620.0 (-100.0%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 75 | GSA CAPITAL PARTNERS LLP | — -32.1K (-100.0%) | — -55.0K (-100.0%) | 0.00% -0.053 pp | 0.00% -0.005 pp | USD— | 3 qtrs SOLD |
| 76 | ADVISORY SERVICES NETWORK, LLC | — -1.1K (-100.0%) | — -1.9K (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 77 | JACOBS LEVY EQUITY MANAGEMENT, INC | — -16.0K (-100.0%) | — -27.4K (-100.0%) | 0.00% -0.026 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 78 | HRT FINANCIAL LP | — -14.0K (-100.0%) | — -23.0K (-100.0%) | 0.00% -0.023 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 79 | INTEGRATED WEALTH CONCEPTS LLC | — -10.2K (-100.0%) | — -17.4K (-100.0%) | 0.00% -0.017 pp | 0.00% 0.000 pp | USD— | 5 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 39 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.03% | 417.2K | 0.60% |
| 2 | iShares Russell 2000 Value ETF IWN | 0.01% | 1.12M | 0.24% |
| 3 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.00% | 118.9K | 0.30% |
| 4 | Global X - Russell 2000 ETF RSSL | 0.00% | 58.1K | 0.08% |
| 5 | Invesco Russell 2000 UCITS ETF RTYS.L | 0.00% | 12.5K | 0.25% |
| 6 | iShares Russell 2000 BuyWrite ETF IWMW | 0.00% | 1.9K | 0.39% |
| 7 | iShares Russell 2000 ETF IWM | 0.00% | 2.78M | 0.19% |
| 8 | iShares U.S. Small Cap Index ETF (CAD-Hedged) XSU.TO | 0.00% | 18.2K | 0.36% |
| 9 | Dimensional - US Vector Equity ETF DXUV | 0.00% | 11.1K | 0.28% |
| 10 | Avantis U.S. Small Cap Equity ETF AVSC | 0.00% | 64.5K | 0.25% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.40
Bearish
Ratio by volume
3.00
Bullish
Buys
19
Sells
48
Shares acquired
8.42M
Shares disposed
295.7K
Cash buys
—
Cash sales
44.00
Net activity
+8,127,644
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Common Stock | 6,060,606 | 3.30 | 20.00M | 19,103,785 | I | ↗ |
| 2026-03-06 | Meisner Derek M | Officer | M-Exempt | A | Common Stock | 2,090 | 1.85 | 3.9K | 176,089 | D | ↗ |
| 2026-02-27 | Meisner Derek M | Officer | M-Exempt | A | Common Stock | 9,406 | 1.85 | 17.4K | 183,405 | D | ↗ |
| 2026-01-28 | Meisner Derek M | Officer | M-Exempt | D | Employee Stock Option (right to buy) | 2,671 | 1.85 | 4.9K | 82,544 | D | ↗ |
| 2026-01-26 | Meisner Derek M | Officer | M-Exempt | A | Common Stock | 15,085 | 1.85 | 27.9K | 189,084 | D | ↗ |
| 2026-01-23 | Meisner Derek M | Officer | S-Sale | D | Common Stock | 5,633 | 1.90 | 10.7K | 173,999 | D | ↗ |
| 2026-01-22 | Zuga Matt | Officer | S-Sale | D | Common Stock | 1,687 | 1.86 | 3.1K | 304,924 | D | ↗ |
| 2026-01-22 | Siemers Eric | Officer | S-Sale | D | Common Stock | 895 | 1.82 | 1.6K | 255,371 | D | ↗ |
| 2026-01-22 | OConnell Daniel Joseph | Director / Officer | S-Sale | D | Common Stock | 2,689 | 1.88 | 5.1K | 881,275 | D | ↗ |
| 2026-01-22 | Meisner Derek M | Officer | S-Sale | D | Common Stock | 1,054 | 1.84 | 1.9K | 179,632 | D | ↗ |
| 2026-01-22 | Barton Russell | Officer | S-Sale | D | Common Stock | 462 | 1.84 | 850.08 | 205,092 | D | ↗ |
| 2026-01-21 | Zuga Matt | Officer | S-Sale | D | Common Stock | 2,473 | 1.81 | 4.5K | 306,611 | D | ↗ |
| 2026-01-21 | Siemers Eric | Officer | S-Sale | D | Common Stock | 2,331 | 1.80 | 4.2K | 256,266 | D | ↗ |
| 2026-01-21 | OConnell Daniel Joseph | Director / Officer | S-Sale | D | Common Stock | 9,346 | 1.81 | 16.9K | 883,964 | D | ↗ |
| 2026-01-21 | Meisner Derek M | Officer | S-Sale | D | Common Stock | 2,247 | 1.81 | 4.1K | 180,686 | D | ↗ |
| 2026-01-21 | Barton Russell | Officer | S-Sale | D | Common Stock | 2,315 | 1.81 | 4.2K | 205,554 | D | ↗ |
| 2026-01-20 | OConnell Daniel Joseph | Director / Officer | A-Award | A | Common Stock | 299,800 | 0.00 | — | 893,310 | D | ↗ |
| 2026-01-16 | Zuga Matt | Officer | A-Award | A | Employee Stock Option (right to buy) | 148,700 | 1.89 | 281.0K | 148,700 | D | ↗ |
| 2026-01-16 | Siemers Eric | Officer | A-Award | A | Employee Stock Option (right to buy) | 148,700 | 1.89 | 281.0K | 148,700 | D | ↗ |
| 2026-01-16 | Schacterle Amy | Officer | A-Award | A | Common Stock | 84,600 | 0.00 | — | 92,303 | D | ↗ |
| 2026-01-16 | Meisner Derek M | Officer | A-Award | A | Employee Stock Option (right to buy) | 148,700 | 1.89 | 281.0K | 148,700 | D | ↗ |
| 2026-01-16 | Doherty James J. | Officer | A-Award | A | Employee Stock Option (right to buy) | 250,300 | 1.89 | 473.1K | 250,300 | D | ↗ |
| 2026-01-16 | Barton Russell | Officer | A-Award | A | Employee Stock Option (right to buy) | 126,900 | 1.89 | 239.8K | 126,900 | D | ↗ |
| 2026-01-12 | OConnell Daniel Joseph | Director / Officer | S-Sale | D | Common Stock | 5,388 | 1.73 | 9.3K | 593,510 | D | ↗ |
| 2026-01-12 | Meisner Derek M | Officer | S-Sale | D | Common Stock | 8,548 | 1.71 | 14.7K | 83,800 | D | ↗ |
| 2026-01-09 | OConnell Daniel Joseph | Director / Officer | S-Sale | D | Common Stock | 12,941 | 1.76 | 22.8K | 598,898 | D | ↗ |
| 2026-01-09 | Meisner Derek M | Officer | S-Sale | D | Common Stock | 5,200 | 1.76 | 9.2K | 92,348 | D | ↗ |
| 2026-01-08 | Zuga Matt | Officer | S-Sale | D | Common Stock | 6,888 | 1.82 | 12.5K | 209,951 | D | ↗ |
| 2026-01-08 | OConnell Daniel Joseph | Director / Officer | S-Sale | D | Common Stock | 8,143 | 1.82 | 14.8K | 611,839 | D | ↗ |
| 2026-01-08 | Meisner Derek M | Officer | S-Sale | D | Common Stock | 6,819 | 1.82 | 12.4K | 127,640 | D | ↗ |
| 2026-01-08 | Doherty James J. | Officer | S-Sale | D | Common Stock | 6,467 | 1.82 | 11.8K | 54,033 | D | ↗ |
| 2026-01-08 | Barton Russell | Officer | S-Sale | D | Common Stock | 3,530 | 1.86 | 6.6K | 123,269 | D | ↗ |
| 2026-01-07 | Zuga Matt | Officer | S-Sale | D | Common Stock | 4,105 | 2.00 | 8.2K | 218,539 | D | ↗ |
| 2026-01-07 | Schacterle Amy | Officer | S-Sale | D | Common Stock | 1,097 | 1.98 | 2.2K | 7,703 | D | ↗ |
| 2026-01-07 | OConnell Daniel Joseph | Director / Officer | S-Sale | D | Common Stock | 37,755 | 1.99 | 75.0K | 619,982 | D | ↗ |
| 2026-01-07 | Meisner Derek M | Officer | S-Sale | D | Common Stock | 10,070 | 1.99 | 20.0K | 134,459 | D | ↗ |
| 2026-01-07 | Doherty James J. | Officer | S-Sale | D | Common Stock | 1,700 | 1.99 | 3.4K | 60,500 | D | ↗ |
| 2026-01-07 | Barton Russell | Officer | S-Sale | D | Common Stock | 1,700 | 1.99 | 3.4K | 126,799 | D | ↗ |
| 2026-01-06 | Zuga Matt | Officer | S-Sale | D | Common Stock | 5,100 | 1.97 | 10.0K | 222,644 | D | ↗ |
| 2026-01-06 | Siemers Eric | Officer | S-Sale | D | Common Stock | 6,834 | 1.97 | 13.4K | 159,464 | D | ↗ |
| 2026-01-06 | OConnell Daniel Joseph | Director / Officer | S-Sale | D | Common Stock | 5,102 | 1.97 | 10.0K | 657,737 | D | ↗ |
| 2026-01-06 | Meisner Derek M | Officer | S-Sale | D | Common Stock | 7,097 | 1.97 | 14.0K | 150,030 | D | ↗ |
| 2026-01-06 | Barton Russell | Officer | S-Sale | D | Common Stock | 3,618 | 1.97 | 7.1K | 128,499 | D | ↗ |
| 2026-01-05 | Zuga Matt | Officer | S-Sale | D | Common Stock | 4,000 | 1.96 | 7.8K | 227,744 | D | ↗ |
| 2026-01-05 | Siemers Eric | Officer | S-Sale | D | Common Stock | 4,000 | 1.96 | 7.8K | 166,298 | D | ↗ |
| 2026-01-05 | OConnell Daniel Joseph | Director / Officer | S-Sale | D | Common Stock | 4,649 | 1.97 | 9.2K | 662,839 | D | ↗ |
| 2026-01-05 | Meisner Derek M | Officer | S-Sale | D | Common Stock | 4,000 | 1.96 | 7.8K | 157,127 | D | ↗ |
| 2026-01-05 | Barton Russell | Officer | S-Sale | D | Common Stock | 4,000 | 1.96 | 7.8K | 132,117 | D | ↗ |
| 2025-11-06 | Golumbeski George | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 1.90 | 95.0K | 50,000 | D | ↗ |
| 2025-06-04 | Stoppel Laura | Director | A-Award | A | Common Stock | 12,800 | 0.00 | — | 12,800 | D | ↗ |
| 2025-06-04 | Stalfort John A III | Director | A-Award | A | Stock Option (right to buy) | 19,500 | 1.07 | 20.9K | 19,500 | D | ↗ |
| 2025-06-04 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Common Stock | 12,800 | 0.00 | — | 12,800 | I | ↗ |
| 2025-06-04 | Porter Derrell | Director | A-Award | A | Common Stock | 12,800 | 0.00 | — | 12,800 | D | ↗ |
| 2025-06-04 | Ives Jeffrey L. | Director | A-Award | A | Common Stock | 12,800 | 0.00 | — | 12,800 | D | ↗ |
| 2025-06-04 | Fountain Nathan B | Director | A-Award | A | Common Stock | 12,800 | 0.00 | — | 19,050 | D | ↗ |
| 2025-06-04 | Drapkin Kimberlee C | Director | A-Award | A | Common Stock | 12,800 | 0.00 | — | 12,800 | D | ↗ |
| 2025-01-23 | Zuga Matt | Officer | S-Sale | D | Common Stock | 28,902 | 1.72 | 49.6K | 231,744 | D | ↗ |
| 2025-01-21 | Zuga Matt | Officer | S-Sale | D | Common Stock | 4,364 | 1.60 | 7.0K | 260,646 | D | ↗ |
| 2025-01-21 | Siemers Eric | Officer | S-Sale | D | Common Stock | 3,219 | 1.59 | 5.1K | 170,298 | D | ↗ |
| 2025-01-21 | OConnell Daniel Joseph | Director / Officer | S-Sale | D | Common Stock | 12,619 | 1.59 | 20.1K | 667,488 | D | ↗ |
| 2025-01-21 | Meisner Derek M | Officer | S-Sale | D | Common Stock | 3,418 | 1.59 | 5.4K | 161,127 | D | ↗ |
| 2025-01-21 | Barton Russell | Officer | S-Sale | D | Common Stock | 2,914 | 1.61 | 4.7K | 136,117 | D | ↗ |
| 2025-01-07 | OConnell Daniel Joseph | Director / Officer | A-Award | A | Common Stock | 225,400 | 0.00 | — | 680,107 | D | ↗ |
| 2025-01-06 | Zuga Matt | Officer | A-Award | A | Employee Stock Option (right to buy) | 100,300 | 1.85 | 185.6K | 100,300 | D | ↗ |
| 2025-01-06 | Siemers Eric | Officer | A-Award | A | Employee Stock Option (right to buy) | 100,300 | 1.85 | 185.6K | 100,300 | D | ↗ |
| 2025-01-06 | Schacterle Amy | Officer | A-Award | A | Common Stock | 8,800 | 0.00 | — | 8,800 | D | ↗ |
| 2025-01-06 | Meisner Derek M | Officer | A-Award | A | Employee Stock Option (right to buy) | 100,300 | 1.85 | 185.6K | 100,300 | D | ↗ |
| 2025-01-06 | Doherty James J. | Officer | A-Award | A | Employee Stock Option (right to buy) | 93,300 | 1.85 | 172.6K | 93,300 | D | ↗ |
| 2025-01-06 | Barton Russell | Officer | A-Award | A | Employee Stock Option (right to buy) | 74,700 | 1.85 | 138.2K | 74,700 | D | ↗ |
| 2025-01-03 | Zuga Matt | Officer | S-Sale | D | Common Stock | 13,235 | 1.84 | 24.4K | 198,210 | D | ↗ |
| 2025-01-03 | Siemers Eric | Officer | S-Sale | D | Common Stock | 10,859 | 1.85 | 20.0K | 106,717 | D | ↗ |
| 2025-01-03 | OConnell Daniel Joseph | Director / Officer | S-Sale | D | Common Stock | 47,778 | 1.84 | 87.9K | 454,707 | D | ↗ |
| 2025-01-03 | Meisner Derek M | Officer | S-Sale | D | Common Stock | 11,122 | 1.84 | 20.5K | 97,745 | D | ↗ |
| 2025-01-03 | Barton Russell | Officer | S-Sale | D | Common Stock | 7,636 | 1.86 | 14.2K | 89,231 | D | ↗ |
| 2024-11-05 | Schacterle Amy | Officer | A-Award | A | Employee Stock Option (right to buy) | 340,000 | 2.95 | 1.00M | 340,000 | D | ↗ |
| 2024-06-10 | Stoppel Laura | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 2.62 | 65.5K | 25,000 | — | ↗ |
| 2024-06-10 | Stalfort John A III | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 2.62 | 65.5K | 25,000 | — | ↗ |
| 2024-06-10 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 25,000 | 2.62 | 65.5K | 25,000 | — | ↗ |
| 2024-06-10 | Porter Derrell | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 2.62 | 65.5K | 25,000 | — | ↗ |
| 2024-06-10 | Ives Jeffrey L. | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 2.62 | 65.5K | 25,000 | — | ↗ |
| 2024-06-10 | Fountain Nathan B | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 2.62 | 65.5K | 25,000 | — | ↗ |
| 2024-06-10 | Drapkin Kimberlee C | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 2.62 | 65.5K | 25,000 | — | ↗ |
| 2024-02-01 | Doherty James J. | Officer | A-Award | A | Employee Stock Option (right to buy) | 601,000 | 3.11 | 1.87M | 601,000 | — | ↗ |
| 2024-01-19 | OConnell Daniel Joseph | Director / Officer | S-Sale | D | Common Stock | 15,200 | 3.47 | 52.8K | 502,485 | — | ↗ |
| 2024-01-19 | Meisner Derek M | Officer | S-Sale | D | Common Stock | 8,933 | 3.48 | 31.0K | 108,867 | — | ↗ |
| 2024-01-18 | Zuga Matt | Officer | S-Sale | D | Common Stock | 4,242 | 3.71 | 15.7K | 211,445 | — | ↗ |
| 2024-01-18 | Siemers Eric | Officer | S-Sale | D | Common Stock | 3,124 | 3.71 | 11.6K | 117,576 | — | ↗ |
| 2024-01-18 | Barton Russell | Officer | S-Sale | D | Common Stock | 2,833 | 3.73 | 10.6K | 96,867 | — | ↗ |
| 2024-01-02 | Zuga Matt | Officer | A-Award | A | Employee Stock Option (right to buy) | 159,000 | 4.23 | 672.6K | 159,000 | — | ↗ |
| 2024-01-02 | Siemers Eric | Officer | A-Award | A | Employee Stock Option (right to buy) | 141,000 | 4.23 | 596.4K | 141,000 | — | ↗ |
| 2024-01-02 | OConnell Daniel Joseph | Director / Officer | A-Award | A | Common Stock | 401,000 | 0.00 | — | 517,685 | — | ↗ |
| 2024-01-02 | Meisner Derek M | Officer | A-Award | A | Common Stock | 91,000 | 0.00 | — | 117,800 | — | ↗ |
| 2024-01-02 | Barton Russell | Officer | A-Award | A | Common Stock | 73,000 | 0.00 | — | 99,700 | — | ↗ |
| 2023-08-17 | Ives Jeffrey L. | Director | S-Sale | D | Common Stock | 2,800 | 6.66 | 18.6K | 0 | — | ↗ |
| 2023-07-21 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 5,161,290 | 7.75 | 40.00M | 13,043,179 | — | ↗ |
| 2023-06-06 | Stoppel Laura | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 5.20 | 130.0K | 25,000 | — | ↗ |
| 2023-06-06 | Stalfort John A III | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 5.20 | 130.0K | 25,000 | — | ↗ |
| 2023-06-06 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | D | Stock Option (Right to Buy) | 25,000 | 5.20 | 130.0K | 25,000 | — | ↗ |
| 2023-06-06 | Porter Derrell | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 5.20 | 130.0K | 25,000 | — | ↗ |
| 2023-06-06 | Ives Jeffrey L. | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 5.20 | 130.0K | 25,000 | — | ↗ |
| 2023-06-06 | Fountain Nathan B | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 5.20 | 130.0K | 25,000 | — | ↗ |
| 2023-06-06 | Drapkin Kimberlee C | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 5.20 | 130.0K | 25,000 | — | ↗ |
| 2023-01-17 | Zuga Matt | Officer | A-Award | A | Common Stock | 33,500 | 0.00 | — | 109,687 | — | ↗ |
| 2023-01-17 | Siemers Eric | Officer | A-Award | A | Employee Stock Option (right to buy) | 120,200 | 0.00 | — | 120,200 | — | ↗ |
| 2023-01-17 | OConnell Daniel Joseph | Officer | A-Award | A | Employee Stock Option (right to buy) | 472,500 | 0.00 | — | 472,500 | — | ↗ |
| 2023-01-17 | Meisner Derek M | Officer | A-Award | A | Employee Stock Option (right to buy) | 120,800 | 0.00 | — | 120,800 | — | ↗ |
| 2023-01-17 | Barton Russell | Officer | A-Award | A | Employee Stock Option (right to buy) | 120,200 | 0.00 | — | 120,200 | — | ↗ |
| 2023-01-04 | Porter Derrell | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-12-29 | Zuga Matt | Officer | M-Exempt | D | Stock Option (right to buy) | 50,000 | 0.00 | — | 401,369 | — | ↗ |
| 2022-09-06 | Meisner Derek M | Officer | A-Award | A | Employee Stock Option (right to buy) | 225,000 | 6.08 | 1.37M | 225,000 | — | ↗ |
| 2022-06-15 | Stoppel Laura | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2022-06-15 | Stalfort John A III | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2022-06-15 | Shah Rajeev M. | Director | A-Award | A | Stock Option (Right to Buy) | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2022-06-15 | Sevigny Jeffrey | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2022-06-15 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 25,000 | 3.59 | 89.8K | 25,000 | — | ↗ |
| 2022-06-15 | Ives Jeffrey L. | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2022-06-15 | Fountain Nathan B | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2022-06-15 | Drapkin Kimberlee C | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2022-04-01 | Drapkin Kimberlee C | Director | A-Award | A | Stock Option Grant (right to buy) | 50,000 | 4.01 | 200.5K | 50,000 | — | ↗ |
| 2022-01-19 | Zuga Matt | Officer | A-Award | A | Employee Stock Option (right to buy) | 150,000 | 5.19 | 778.5K | 150,000 | — | ↗ |
| 2022-01-19 | Siemers Eric | Officer | A-Award | A | Employee Stock Option (right to buy) | 90,000 | 5.19 | 467.1K | 90,000 | — | ↗ |
| 2022-01-19 | OConnell Daniel Joseph | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 455,000 | 5.19 | 2.36M | 455,000 | — | ↗ |
| 2022-01-19 | Barton Russell | Officer | A-Award | A | Employee Stock Option (right to buy) | 135,000 | 5.19 | 700.7K | 135,000 | — | ↗ |
| 2021-11-30 | OConnell Daniel Joseph | Director / Officer | M-Exempt | A | Common Stock | 1,118 | 4.47 | 5.0K | 2,685 | — | ↗ |
| 2021-07-06 | Zuga Matt | Officer | C-Conversion | A | Common Stock | 26,187 | 0.00 | — | 26,187 | — | ↗ |
| 2021-07-06 | Stalfort John A III | Director | P-Purchase | A | Common Stock | 35,000 | 16.00 | 560.0K | 172,324 | — | ↗ |
| 2021-07-06 | Sands Capital Ventures Discovery Fund III, L.P. | 10% Owner | P-Purchase | A | Common Stock | 450,000 | 14.88 | 6.70M | 3,417,075 | — | ↗ |
| 2021-07-06 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | C-Conversion | A | Common Stock | 1,184,366 | 0.00 | — | 1,184,336 | — | ↗ |
| 2021-07-06 | OConnell Daniel Joseph | Director / Officer | M-Exempt | D | Warrant (Right to Buy) | 35 | 4.47 | 156.45 | 0 | — | ↗ |
| 2021-07-06 | Manning Paul B | 10% Owner | P-Purchase | A | Common Stock | 312,500 | 16.00 | 5.00M | 3,352,693 | — | ↗ |
| 2021-07-06 | Hardie Robert D. | 10% Owner | C-Conversion | D | Series B Preferred Stock | 657,985 | 0.00 | — | 0 | — | ↗ |
| 2021-07-06 | Fountain Nathan B | Director | P-Purchase | A | Common Stock | 6,250 | 16.00 | 100.0K | 6,250 | — | ↗ |
| 2021-06-30 | Zuga Matt | Officer | — | D | Series A-1 Preferred Stock | 15,659 | 0.00 | — | 0 | — | ↗ |
| 2021-06-30 | Stoppel Laura | Director | A-Award | A | Stock Option (Right to Buy) | 34,000 | 16.00 | 544.0K | 34,000 | — | ↗ |
| 2021-06-30 | Stalfort John A III | Director | — | I | Series B Preferred | 131,595 | 0.00 | — | 0 | — | ↗ |
| 2021-06-30 | Siemers Eric | Officer | — | D | Stock Option (Right to Buy) | 186,800 | 0.72 | 134.5K | 0 | — | ↗ |
| 2021-06-30 | Sevigny Jeffrey | Director | — | D | Stock Option (Right to Buy) | 46,420 | 0.72 | 33.4K | 0 | — | ↗ |
| 2021-06-30 | Sands Capital Ventures Discovery Fund III, L.P. | 10% Owner | — | D | Series A-1 Preferred Stock | 1,124,729 | 0.00 | — | 0 | — | ↗ |
| 2021-06-30 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | — | I | Series B Preferred Stock | 588,850 | 0.00 | — | 0 | — | ↗ |
| 2021-06-30 | OConnell Daniel Joseph | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 1,419 | — | ↗ |
| 2021-06-30 | Manning Paul B | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 89,709 | — | ↗ |
| 2021-06-30 | Ives Jeffrey L. | Director | — | D | Stock Option (Right to Buy) | 7,828 | 4.47 | 35.0K | 0 | — | ↗ |
| 2021-06-30 | Hardie Robert D. | 10% Owner | — | I | Series B Preferred Stock | 2,076,326 | 0.00 | — | 0 | — | ↗ |
| 2021-06-30 | Fountain Nathan B | Director | A-Award | A | Stock Option (Right to Buy) | 34,000 | 16.00 | 544.0K | 34,000 | — | ↗ |
| 2021-06-30 | Barton Russell | Officer | — | D | Stock Option (Right to Buy) | 46,420 | 0.72 | 33.4K | 0 | — | ↗ |
| 2008-01-28 | STOVER JACK E | Director | A-Award | A | Stock Option | 15,000 | 0.69 | 10.4K | 15,000 | — | ↗ |
| 2008-01-28 | Kogod Dennis | Director | A-Award | A | Stock Option | 15,000 | 0.69 | 10.4K | 15,000 | — | ↗ |
| 2007-07-12 | STOVER JACK E | Director | A-Award | A | Common Stock (Restricted) | 40,625 | 0.00 | — | 40,625 | — | ↗ |
| 2007-07-12 | Kogod Dennis | Director | A-Award | A | Common Stock (Restricted) | 9,375 | 0.00 | — | 9,375 | — | ↗ |
| 2007-05-10 | Kogod Dennis | Director | A-Award | A | Common stock (restricted) | 15,244 | 0.00 | — | 15,244 | — | ↗ |
| 2007-01-11 | STOVER JACK E | Director | A-Award | A | Stock Option | 15,000 | 0.51 | 7.7K | 15,000 | — | ↗ |
| 2007-01-11 | Kogod Dennis | Director | A-Award | A | Stock Option | 15,000 | 0.51 | 7.7K | 15,000 | — | ↗ |
| 2006-11-09 | STOVER JACK E | Director | A-Award | A | Common Stock (restricted) | 26,563 | 0.00 | — | 26,563 | — | ↗ |
| 2006-11-09 | Kogod Dennis | Director | A-Award | A | Common Stock (restricted) | 7,031 | 0.00 | — | 7,031 | — | ↗ |
| 2006-09-15 | STOVER JACK E | Director | P-Purchase | A | Common stock | 1,000 | 0.70 | 700.00 | 1,000 | — | ↗ |
| 2006-06-12 | Kogod Dennis | Director | P-Purchase | A | Common Stock | 10,000 | 1.12 | 11.2K | 10,000 | — | ↗ |
| 2006-01-11 | STOVER JACK E | Director | A-Award | A | Stock Option (right to buy) | 5,000 | 1.66 | 8.3K | 5,000 | — | ↗ |
| 2006-01-11 | Kogod Dennis | Director | A-Award | A | Stock Option (right to buy) | 10,000 | 1.66 | 16.6K | 10,000 | — | ↗ |
| 2006-01-11 | HAUSMAN MARVIN S MD | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 1.66 | 24.9K | 15,000 | — | ↗ |
| 2006-01-11 | EDDLEMAN ROY T | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 1.66 | 24.9K | 15,000 | — | ↗ |
| 2005-10-05 | HAUSMAN MARVIN S MD | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 1.80 | 54.0K | 30,000 | — | ↗ |
| 2005-05-16 | STOVER JACK E | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 2.48 | 37.2K | 15,000 | — | ↗ |
| 2005-05-16 | Kogod Dennis | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 2.48 | 37.2K | 15,000 | — | ↗ |
| 2005-05-16 | HAUSMAN MARVIN S MD | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 2.48 | 37.2K | 15,000 | — | ↗ |
| 2004-11-02 | STOVER JACK E | Director | — | D | Stock Option (right to buy) | 30,000 | 2.97 | 89.1K | 0 | — | ↗ |
| 2003-10-30 | HAUSMAN MARVIN S MD | Director | — | D | Stock Option (right to buy) | 18,000 | 1.00 | 18.0K | 0 | — | ↗ |
| 2003-10-30 | EDDLEMAN ROY T | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2003-10-29 | HAUSMAN MARVIN S MD | Director | — | D | Warrants (right to buy) | 100,000 | 2.50 | 250.0K | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
60.57M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Daniel O’Connell Chief Executive Officer | 646.4K | — | 412.5K | 478.3K | 305.7K | 20.7K | 1.86M | 47.80% | ↗ |
| 2 | 2025 | Jim Doherty President and Chief Development Officer | 520.0K | — | 115.1K | 133.4K | 223.6K | 20.8K | 1.01M | 24.53% | ↗ |
| 3 | 2025 | Matthew Zuga Chief Financial Officer and Chief Business Officer | 487.0K | — | 123.6K | 143.4K | 173.0K | 21.8K | 948.8K | 28.14% | ↗ |
| 4 | 2024 | Daniel O’Connell Chief Executive Officer | 621.5K | — | 1.70M | 2.04M | 406.8K | 19.3K | 4.78M | 78.09% | ↗ |
| 5 | 2024 | Jim Doherty President and Chief Development Officer | 458.3K | — | — | 1.49M | 210.9K | 19.9K | 2.18M | 68.42% | ↗ |
| 6 | 2024 | Jim Doherty President and Chief Development Officer | 458.3K | — | — | 1.49M | 210.9K | 19.9K | 2.18M | 68.42% | ↗ |
| 7 | 2024 | Matthew Zuga Chief Financial Officer and Chief Business Officer | 468.3K | — | 448.4K | 538.0K | 215.8K | 19.1K | 1.69M | 58.38% | ↗ |
| 8 | 2023 | Daniel O’Connell Chief Executive Officer | 597.6K | — | 696.5K | 2.19M | 427.3K | 18.4K | 3.93M | 73.45% | ↗ |
| 9 | 2023 | Matthew Zuga Chief Financial Officer and Chief Business Officer | 450.3K | — | 204.7K | 699.0K | 234.1K | 18.2K | 1.61M | 56.26% | ↗ |
| 10 | 2023 | Derek Meisner Chief Legal Officer | 455.7K | 45.0K | 163.7K | 559.9K | 236.9K | 15.3K | 1.48M | 49.01% | ↗ |
| 11 | 2022 | Daniel O’Connell President and Chief Executive Officer | 570.5K | — | — | 1.76M | 290.9K | 39.8K | 2.66M | 66.15% | ↗ |
| 12 | 2022 | Daniel O’Connell Chief Executive Officer | 570.5K | — | — | 1.76M | 290.9K | 39.8K | 2.66M | 66.15% | ↗ |
| 13 | 2022 | Derek Meisner Chief Legal Officer | 141.7K | 45.0K | — | 1.04M | 52.9K | 538.00 | 1.28M | 81.23% | ↗ |
| 14 | 2022 | Matthew Zuga Chief Financial Officer and Chief Business Officer | 429.8K | — | — | 580.5K | 163.1K | 15.3K | 1.19M | 48.83% | ↗ |
| 15 | 2021 | Daniel O’Connell President and Chief Executive Officer | 524.6K | — | — | 676.2K | 275.4K | 1.6K | 1.48M | 45.76% | ↗ |
| 16 | 2021 | Daniel O’Connell President and Chief Executive Officer | 524.6K | — | — | 676.2K | 275.4K | 1.6K | 1.48M | 45.76% | ↗ |
| 17 | 2021 | Matthew Zuga Chief Financial Officer and Chief Business Officer | 315.4K | 55.0K | — | 257.3K | 150.9K | 200.00 | 778.8K | 33.03% | ↗ |
| 18 | 2021 | Matthew Zuga Chief Financial Officer and Chief Business Officer | 315.4K | 55.0K | — | 257.3K | 150.9K | 200.00 | 778.8K | 33.03% | ↗ |
| 19 | 2021 | Eric Siemers, M.D. Chief Medical Officer | 336.2K | — | — | 177.3K | 124.3K | 200.00 | 637.9K | 27.79% | ↗ |
| 20 | 2020 | Daniel O’Connell President and Chief Executive Officer | 240.0K | 96.0K | — | — | — | — | 336.0K | 0.00% | ↗ |
| 21 | 2020 | Eric Siemers, M.D. Chief Medical Officer | 180.0K | 57.6K | — | — | — | — | 237.6K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Daniel J. O'Connell | Chief Executive Officer & Director | 972.7K | male |
| James Doherty | President & Chief Development Officer | 764.4K | — |
| Derek Meisner | Chief Legal Officer & Corporate Secretary | 752.9K | male |
| Matt Zuga | Chief Financial Officer & Chief Business Officer | 681.8K | male |
| Russell Barton | Chief Operating Officer | 223.7K | male |
| William L. Klein | Co-Founder | 42.0K | — |
| Grant A. Krafft | Co-Founder | 42.0K | — |
| Caleb E. Finch | Co-Founder | 42.0K | — |
| Julie Bockenstette | Chief People Officer | — | female |
| Alex Braun | Vice President & Head of Investor Relations | — | female |
| Kelly Carranza | Senior Vice President of Finance & Accounting and Corporate Controller | — | female |
| Robyn Moxon | Associate Director of Communications | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ABOS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
